Bladder Cancer: Pathways to a Cure
Over 75,000 Americans will be diagnosed with bladder cancer this year. Backed by the Greenberg Bladder Cancer Institute, Drs. Trinity Bivalacqua and Michael Johnson are working to improve bladder cancer care. In this webinar, they will discuss how Hopkins doctors treat bladder cancer, from diagnosis and treatment, to new therapies on the horizon.
Treating Non-Muscle Invasive Bladder Cancer
Trinity J. Bivalacqua, M.D., Ph.D., Johns Hopkins Medical Institutions speaks at the BCAN Washington D.C. Patient Forum.
Trinity J. Bivalacqua, M.D, Ph.D., Johns Hopkins Medicine, Urology
Trinity J. Bivalacqua, M.D., Ph.D., Assistant Professor of Urology and Oncology graduated from Tulane University with undergraduate, graduate and medical degrees. He joined the faculty after completing his General Surgery and Urology training at Johns Hopkins Hospital.
Bladder Cancer | Q&A
Surgeon, Armine Smith, from the Brady Urological Institute answers questions about bladder cancer, diagnosis and treatment options available.
Bladder Cancer | John's Story
Bladder Cancer | Warren's Story
After receiving treatment for non-muscle invasive bladder cancer and discovering that his tumor was not responding Dr. Warren Brill was referred to Johns Hopkins.
The Future of Bladder Cancer | Johns Hopkins Greenberg Bladder Cancer Institute